Compare Sai Parenteral's with Similar Stocks
Loading Valuation Snapshot...
Stock DNA
Pharmaceuticals & Biotechnology
INR 2,498 Cr (Small Cap)
172.00
NA
0.00%
-0.17
2.91%
5.00
Revenue and Profits:
Net Sales:
57 Cr
(Quarterly Results - Mar 2026)
Net Profit:
10 Cr
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available
Announcements 
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
29-May-2026 | Source : BSEEarnings Call Transcript
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
28-May-2026 | Source : BSEReceipt of Order
Announcement under Regulation 30 (LODR)-Investor Presentation
26-May-2026 | Source : BSEInvestor Presentation
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
1.90
Debt to EBITDA (avg)
8.61
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.46
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
18.59%
ROCE (avg)
5.37%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
172
Industry P/E
0
Price to Book Value
5.00
EV to EBIT
108.42
EV to EBITDA
61.21
EV to Capital Employed
5.82
EV to Sales
6.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.37%
ROE (Latest)
2.91%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
Bullish
OBV
No Trend
Shareholding Snapshot : Apr 2026
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 1 Schemes (3.81%)
FIIs
Held by 9 FIIs (5.73%)
Promoter with highest holding
Vijitha Gorrepati (0.29%)
Highest Public shareholder
Quant Mutual Fund - Quant Small Cap Fund (0.038%)
Individual Investors Holdings
22.67%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
56.79
38.48
47.58%
Operating Profit (PBDIT) excl Other Income
13.22
3.98
232.16%
Interest
3.42
2.12
61.32%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.95
0.36
2,663.89%
Operating Profit Margin (Excl OI)
23.28%
10.34%
12.94%
Values in Rs Cr.
Net Sales
Not Applicable: The company has declared_date for only one period
Standalone Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Standalone) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
162.25
124.27
30.56%
Operating Profit (PBDIT) excl Other Income
30.58
26.95
13.47%
Interest
8.77
7.31
19.97%
Exceptional Items
0.00
0.00
Standalone Net Profit
16.78
10.34
62.28%
Operating Profit Margin (Excl OI)
18.85%
21.69%
-2.84%
Values in Rs Cr.
Net Sales
YoY Growth in year ended Mar 2026 is 30.56% vs 9.11% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is 62.28% vs 44.41% in Mar 2025
About Sai Parenterals Ltd 
Sai Parenterals Ltd
Small Cap
Pharmaceuticals & Biotechnology
Sai Parenteral's Limited was originally incorporated as `Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad. Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to `Sai Parenteral's Limited' w.e.f January 17, 2022.
Company Coordinates 
No Company Details Available






